Hx of prostate cancer, evaluate for further disease, biopsy to follow, considering active surveillance.Additional history per EMR:PSA history:2014: 4 ng/mLJanuary 2015: 5 ng/mLFeb 17, 2015: 7.07 ng/mLProstate biopsy 4/20/2015:Right apex Gleason 3+3, 1mm PELVIS:PROSTATE:Prostate Size: 5.7 x 4.9 cm.Peripheral Zone: Single focus of T2/ADC hypointense signal abnormality is seen in the mid gland/apex in the midline (series 901, image 19). No definite pathologic enhancement is seen on postcontrast sequences. This lesion is indeterminate. No other lesions suspicious for known prostatic adenocarcinoma are identified.Central Gland: Transitional zone is enlarged with multiple nodules demonstrating benign morphology without suspicious characteristics.Seminal Vesicles: Seminal vesicles are unremarkable.Extracapsular Extension: No evidence of extracapsular extension of a prostatic lesion.BLADDER: No significant abnormality noted.LYMPH NODES: No significant abnormality noted.BONES, SOFT TISSUES: No significant abnormality noted.OTHER: No significant abnormality noted.
Questionable small midline lesion in the mid gland/apex, as above. 